Literature DB >> 23899282

The National Health Service Bowel Cancer Screening Program: the early years.

Colin J Rees1, Roisin Bevan.   

Abstract

The National Health Service Bowel Cancer Screening Program (NHS BCSP) was developed to improve outcomes from colorectal cancer, the third most frequent cancer and the second highest cause of cancer deaths in the UK. Screening pilot programs were developed after previous trials demonstrated a reduction in mortality with the use of fecal occult blood population screening. A successful pilot period led to the roll out of national biennial screening for all 60-69 year olds in 2006, and extended to 60-74 year olds in 2010. To the end of 2012, there have been over 16 million invitations to screening, with uptake of 55.35%. FOBt positivity was 2.08%. Almost 15,000 cancers have been identified; screen-detected cancers have been shown to be at an earlier stage than non-screen-detected, with 35% Dukes' stage A. The BCSP provides high quality colonoscopy with low adverse events rates. It is also a rich data source for research.

Entities:  

Mesh:

Year:  2013        PMID: 23899282     DOI: 10.1586/17474124.2013.811045

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  17 in total

1.  Optimal Management of a Synchronous Diagnosis of Phaeochromocytoma and Colorectal Neoplasia.

Authors:  Ridwaan Sohawon; Peter Truran; Jonathan Webster; Barney J Harrison; Sabapathy P Balasubramanian
Journal:  Indian J Surg Oncol       Date:  2017-02-22

Review 2.  Quality indicators for colonoscopy: Current insights and caveats.

Authors:  Hendrikus Jm Pullens; Peter D Siersema
Journal:  World J Gastrointest Endosc       Date:  2014-12-16

Review 3.  Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India.

Authors:  Sudha Sivaram; Gautam Majumdar; Douglas Perin; Ashrafun Nessa; Mireille Broeders; Elsebeth Lynge; Mona Saraiya; Nereo Segnan; Rengaswamy Sankaranarayanan; Preetha Rajaraman; Edward Trimble; Stephen Taplin; G K Rath; Ravi Mehrotra
Journal:  Lancet Oncol       Date:  2018-02       Impact factor: 41.316

4.  Multicentre randomised controlled trial comparing standard and high resolution optical technologies in colorectal cancer screening.

Authors:  Simona Di Caro; Lucia Fini; Roser Vega; Konstantinos C Fragkos; Sunil Dolwani; John Green; Lesley-Ann Smith; Conrad Beckett; Ewen Cameron; Matthew Banks
Journal:  Frontline Gastroenterol       Date:  2019-02-26

5.  Colonoscopic polyp detection rate is stable throughout the workday including evening colonoscopy sessions.

Authors:  David Thurtle; Michael Pullinger; Jordan Tsigarides; Iris McIntosh; Carla Steytler; Ian Beales
Journal:  F1000Res       Date:  2014-05-13

6.  A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional survey.

Authors:  Lindsay C Kobayashi; Jo Waller; Christian von Wagner; Jane Wardle
Journal:  BMC Public Health       Date:  2016-07-29       Impact factor: 3.295

Review 7.  The NHS Bowel Cancer Screening Program: current perspectives on strategies for improvement.

Authors:  Sara Koo; Laura Jane Neilson; Christian Von Wagner; Colin John Rees
Journal:  Risk Manag Healthc Policy       Date:  2017-12-04

8.  Outcomes and adverse factors for endoscopic mucosal resection (EMR) of colorectal polyps in elderly patients.

Authors:  Thomas Skouras; Ashley Bond; Asimina Gaglia; Laura Bonnett; Meng Jiang Lim; Sanchoy Sarkar
Journal:  Frontline Gastroenterol       Date:  2020-02-25

9.  Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.

Authors:  J Geraghty; P Butler; H Seaman; J Snowball; S Sarkar; R Blanks; S Halloran; K Bodger; C J Rees
Journal:  Br J Cancer       Date:  2014-09-16       Impact factor: 7.640

10.  Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial.

Authors:  Lesley M McGregor; Christian von Wagner; Wendy Atkin; Ines Kralj-Hans; Stephen P Halloran; Graham Handley; Richard F Logan; Sandra Rainbow; Steve Smith; Julia Snowball; Mary C Thomas; Samuel G Smith; Gemma Vart; Rosemary Howe; Nicholas Counsell; Allan Hackshaw; Stephen Morris; Stephen W Duffy; Rosalind Raine; Jane Wardle
Journal:  Gastroenterol Res Pract       Date:  2016-03-16       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.